MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts
cancer cell

Revolutionizing Cancer Care: Neoantigen Selective TILs at the Orlando Health Cancer Institute Now Enrolling for Breast, Uveal Melanoma, Cutaneous Melanoma, NSCLC, HeadNeck Carcinomas

I have sponsor, regulatory and IRB permissions/approval to post this blog publicly on social media. I am very excited about this protocol using TILs for breast cancer, colorectal, uveal melanomas, and now also inclusive of cutaneous melanoma, nsclc, head/neck carcinoma. Further details can be found here at the sponsor site and at clinical trials.gov. Adoptive …

Read On »

Oncodox: To Be Aggressive or To Be Careful!

Oncodox: To Be Aggressive or To Be Careful!

Oncologists face many ethical challenges in their practice, including balancing honesty and optimism, aggressive and careful treatment, appropriate treatment for the elderly, and when to refer patients to hospice. Telling patients the truth about their diagnosis and more importantly the prognosis while also providing hope can be difficult, as can balancing the intensity of treatment …

Read On »

Oncodox: To Be Optimistic or To Be Honest?

Oncodox: To Be Optimistic or To Be Honest?

Oncologists face many ethical challenges in their practice, including balancing honesty and optimism, aggressive and careful treatment, appropriate treatment for the elderly, and when to refer patients to hospice. Telling patients the truth about their diagnosis and more importantly the prognosis while also providing hope can be difficult, as can balancing the intensity of treatment …

Read On »

Tumor Boards: A Vital Part of Cancer Care

Tumor Boards: A Vital Part of Cancer Care 

A tumor board is a meeting where a team of healthcare professionals and ancillary providers, including medical, radiation oncologists, radiologists, surgeons, interventionalist, and pathologists, come together to discuss the treatment plan for a patient with cancer. Nurses, extenders, navigators, pharmacists, palliative care, research, hospitalist, students, residents, fellows, nutritionists, and many other folks can participate depending …

Read On »

Breaking Down Barriers: The Drawbacks of Participating in Clinical Trials

Breaking Down Barriers: The Drawbacks of Participating in Clinical Trials

Previously I discussed the advantages of participating in a clinical trial however it is also important to educate the public on all aspects of clinical trials, including both the potential drawbacks. Here are seven key bullet points on the disadvantages of participating in a clinical trial:  Time commitment Clinical trials often require a significant amount of time …

Read On »

ctDNA is a Game-Changer in Cancer Management: Top 5 Reasons I Use ctDNA in Cancer Care

ctDNA is a Game-Changer in Cancer Management: Top 5 Reasons I Use ctDNA in Cancer Care

As an oncologist, I have seen the importance of using circulating tumor DNA (ctDNA) analysis in cancer diagnosis and treatment. ctDNA is a simple blood test that can provide valuable information about a patient’s cancer, making it a valuable tool in the fight against this disease.  Signatera is a technology developed by Natera that uses tumor-informed …

Read On »

The Top Seven Benefits of Clinical Trial Participation

The Top Seven Benefits of Clinical Trial Participation

Cancer can be a scary thing, but did you know that there is a way for you to take part in the fight against cancer? It’s called participating in a clinical trial. Clinical trials are research studies that test new ways to prevent, detect, or treat diseases. If you or a loved one has cancer, …

Read On »

close up photo of person holding syringe

A New Way to Tackle Cancer: Understanding Intratumoral Therapy

Imagine if your body had superpowers to fight cancer! Well, that’s exactly what a new treatment called Intratumoral therapy does. By giving your body the tools it needs to attack cancer cells, this treatment is changing the game for patients with unresectable or metastatic melanoma. Some of the treatments are directly killing cancer cells itself …

Read On »

Understanding Your Tumor’s Progress: How We Monitor Response to Treatment

Understanding Your Tumor’s Progress: How We Monitor Response to Treatment

As a physician, it is important to communicate complex medical concepts in a way that is easy to understand for patients. When patients are diagnosed and are undergoing treatment a common question I get is “how do we know the treatment is working”? My crystal ball does not work very well, and I tell my …

Read On »

Treatment Options for Metastatic Gastric Cancer: The Promise of Zolbetuximab and Nivolumab Combinations from GI ASCO 2023

Treatment Options for Metastatic Gastric Cancer: The Promise of Zolbetuximab and Nivolumab Combinations from GI ASCO 2023

Metastatic gastric cancer, also known as stage IV gastric cancer, is a serious and advanced form of the disease in which the cancer has spread beyond the stomach to other parts of the body. The current standard of care for patients with metastatic gastric cancer includes chemotherapy, Her2 targeted therapy and immunotherapy. However, there remains …

Read On »

  • Previous
  • Page 1
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Next

Recent Posts

  • When the System Works: A TIL Therapy Story
  • The Next Generation of TIL Therapy Has Arrived — And It Skips the IL-2
  • A Third Chance for RP1: An Option Melanoma Patients Still Need
  • The BRAF Pathway to TIL Program: Why Earlier Planning May Change the Treatment Journey for Melanoma Patients
  • The TIL Journey: From a Medical Oncologist’s Perspective

Categories

  • Art of Oncology (99)
  • Current News (17)
  • Immunotherapy News (13)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Reflections (3)
  • Research Advances (121)
    • Clinical Trials (52)
    • Immunotherapy (33)
    • New Treatments and Therapies (44)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (127)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (15)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (3)
    • Lung Cancer (11)
    • Lymphoma (3)
    • Melanoma (35)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (5)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (9)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts
© 2026 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • 🧠 How I Create My Blog Posts